Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

NMDA antagonists reported by Zeneca

July 5, 1996

Novo Nordisk claims mGluR antagonists for CNS disorders

July 5, 1996

Toyama discloses NGF-promoting agents

July 5, 1996

Sumitomo claims psychotropic lactam derivatives

July 5, 1996

5-HT2 ligands claimed by Janssen

July 5, 1996

Anxiolytic/antidepressant 5-HT1A receptor ligands from AHP

July 5, 1996

Lilly discloses antiobesity proteins

July 5, 1996

NPY1 ligands claimed by Pfizer

July 5, 1996

HHS scientist discovers cartilage formation stimulant

July 5, 1996

Kyowa Hakko isolates antitumor/antibacterial compound from Streptomyces

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...